DEXAMETHASONE SODIUM PHOSPHATE — MYLAN LABS LTD, approved 2024-06-05 (ANDA040803).
199,283 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.